###begin article-title 0
Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease
###end article-title 0
###begin p 1
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 844 845 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1002 1005 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 357 365 <span type="species:ncbi:9606">children</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
Polymorphism of angiotensin converting enzyme (ACE) gene is reported to be associated with ischemic heart disease, hypertrophic cardiomyopathy, and idiopathic dilated cardiomyopathy. In this study, we investigated the relationship between Kawasaki disease and insertion/deletion polymorphism of ACE gene. Fifty five Kawasaki disease patients and 43 healthy children were enrolled. ACE genotype was evaluated from each of the subjects' DNA fragments through polymerase chain reaction (PCR). Frequencies of ACE genotypes (DD, ID, II) were 12.7%, 60.0%, 27.3% in Kawasaki group, and 41.9%, 30.2%, 27.9% in control group respectively, indicating low rate of DD and high rate of ID genotype among Kawasaki patients (p<0.01). Comparing allelic (I, D) frequencies, I allele was more prevalent in Kawasaki group than in control group (57.3% vs. 43.0%, p<0.05). In Kawasaki group, both genotype and allelic frequencies were not statistically different between those with coronary dilatations and those without. ACE gene I/D polymorphism is thought to be associated with Kawasaki disease but not with the development of coronary dilatations.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 296 304 <span type="species:ncbi:9606">children</span>
###xml 512 520 <span type="species:ncbi:9606">patients</span>
Kawasaki disease is an acute systemic vasculitis and its diagnosis is made on clinical features. Main complication of the disease is coronary artery lesion that may result in myocardial infarction or sudden death. Coronary artery aneurysms or ectasia develop in approximately 15-25% of untreated children (1). Since the intravenous immune globulin (IVIG) and aspirin therapy have been introduced, its mortality rate has decreased to 0.1%, but cardiac sequelae continues to occur in about 13% of Kawasaki disease patients (2).
###end p 3
###begin p 4
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 642 648 <span type="species:ncbi:9606">person</span>
The etiology of Kawasaki disease is largely unknown despite the various suggested hypotheses. Based on epidemiologic and clinical manifestations, it is thought that Kawasaki disease is caused by some infectious agents (3-10). Hypercytokinemia and hyperchemokinemia have also been observed and are thought to cause vascular injuries by inflammatory reaction and immunologic activation (11). Genetic factors are also thought to have influences on the development and progress of Kawasaki disease (12, 13). Up to present days, Kawasaki disease is thought to be an infectious disease manifested by immunologic reaction in genetically susceptable person.
###end p 4
###begin p 5
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
Angiotensin converting enzyme (ACE) breaks down the potent vasodilator, bradykinin to its inactivate metabolite and catalyzes angiotensin I to angiotensin II. Angiotensin II promotes hyperplasia and hypertrophy of vascular smooth muscle cells, induces the production of proinflammatory cytokines and causes endothelial dysfunction by free radical generation. By playing an important role in cardiovascular regulatory system, ACE gene has been proposed to be associated with various cardiovascular diseases, such as ischemic heart disease, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, and vascular hypertrophy (14). Among the different ACE genetic loci, the insertion/deletion polymorphism coded within intron 16 has been studied in many literature to find the association with such diseases.
###end p 5
###begin p 6
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
However, there has been few studies regarding the association between the polymorphism of ACE gene and Kawasaki disease. The present study investigates whether the I/D polymorphism of ACE gene (DD, ID, II) is associated with the prevalence and severity of Kawasaki disease among Korean pediatric populations.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Study subjects
###end title 8
###begin p 9
###xml 20 28 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">children</span>
###xml 447 457 <span type="species:ncbi:3747">strawberry</span>
###xml 745 753 <span type="species:ncbi:9606">patients</span>
Fifty five Kawasaki patients (mean age 28.2+/-25.2 months) diagnosed at Ewha Womans University Mokdong Hospital from January 2001 to June 2003, and 43 healthy children (mean age 28.5+/-17.2 months) were enrolled. Kawasaki disease was diagnosed by its clinical features, that is fever lasting for at least 5 days, accompanied by 4 of the 5 classical signs: 1) bilateral bulbar conjunctival injection; 2) pharynx, injected and/or dry fissured lips, strawberry tongue; 3) changes of the peripheral extremities in the acute phase or periungal desquamation in the subacute phase; 4) nonvesicular rash; 5) cervical adenopathy, >/=1.5 cm. The diagnosis was made if he/she had typical manifestations even before less than 5 febrile days of illness. All patients were treated with immunoglobulin (2 g/kg) on the day of diagnosis. High dose (50 mg/kg/day) aspirin was given from the day of diagnosis and its dosage was changed to 5 mg/kg/day after 2 nonfebrile consecutive days.
###end p 9
###begin p 10
###xml 163 171 <span type="species:ncbi:9606">children</span>
###xml 196 204 <span type="species:ncbi:9606">children</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
Two dimensional echocardiography was done to evaluate cardiac complications. Coronary arterial lesion was defined as following: 1) inner diameter that is >3 mm in children <5 yrs old and >4 mm in children >/=5 yrs old; 2) internal diameter of a segment >/=1.5 times that of an adjacent segment; or 3) lumen with irregular surface. Among these patients, 17 showed coronary dilatations and 38 did not.
###end p 10
###begin p 11
Informed consent was obtained from his/her parents prior to the participation in the study. The study was approved by the hospital's ethics commitee.
###end p 11
###begin title 12
ACE genotyping
###end title 12
###begin p 13
###xml 443 446 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
Each of the subjects' DNA was extracted from whole blood at the time of diagnosis using QIAamp DNA Blood Mini Kit (Gene Company LTD., Chai Wan, Hong Kong). DNA fragments were amplified through polymerase chain reaction (PCR), which was carried out in a total volume of 10 microL containing 50 ng of genomic DNA, 200 mM dNTPs, 0.3 mM/mL of each primers (5'-CTGGAGACCACTCCCATCCTTTCT); (5'-GATGTGGCCATCACATTCGTCAGAT) in PCR buffer with 0.5 units Taq DNA polymerase (Takara, Shiga, Japan). After the initial denaturation step (10 min at 95℃), 35 cycles were repeated for 30 sec at 94℃, 30 sec at 52℃, 90 sec at 72℃, and 5 min at 72℃. DNA fragments were then separated by electrophoresis on 2.5% agarose gel.
###end p 13
###begin title 14
Statistical analysis
###end title 14
###begin p 15
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Student's t-test was used to compare the demographic characteristics between the two groups. Chi square test and Fisher exact test were performed to compare the genotype and allelic frequencies between the two groups. Its frequencies were compared by odds ratio. p value less than 0.05 was considered significant.
###end p 15
###begin title 16
RESULTS
###end title 16
###begin p 17
###xml 260 267 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 35 39 <span type="species:ncbi:9606">boys</span>
###xml 47 52 <span type="species:ncbi:9606">girls</span>
###xml 112 116 <span type="species:ncbi:9606">boys</span>
###xml 124 129 <span type="species:ncbi:9606">girls</span>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 242 246 <span type="species:ncbi:9606">boys</span>
###xml 253 258 <span type="species:ncbi:9606">girls</span>
The mean age of Kawasaki group (28 boys and 27 girls) was 28.2+/-25.2 months, and that of the control group (30 boys and 13 girls) was 28.5+/-17.2 months. Among 55 Kawasaki disease patients, coronary dilatation was observed in 17 patients (8 boys and 9 girls, Table 1)
###end p 17
###begin p 18
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 280 287 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
Frequencies of ACE genotypes (DD, ID, II) were 12.7%, 60.0%, 27.3% in Kawasaki group, and 41.9%, 30.2%, 27.9% in control group respectively, indicating low rate of DD genotype (p<0.01, odds ratio=0.2) and high rate of ID genotype (p<0.01, odds ratio=3.3) among Kawasaki patients (Table 2).
###end p 18
###begin p 19
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
Comparing allelic (I, D) frequencies, I allele was more prevalent in Kawasaki group than in control group (57.3% vs. 43.0%, p<0.05, odds ratio=1.78, Table 3).
###end p 19
###begin p 20
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
In Kawasaki group, both genotype (DD, ID, II) and allelic frequencies were not statistically different between those with coronary dilatations and those without (Table 4, 5).
###end p 20
###begin title 21
DISCUSSION
###end title 21
###begin p 22
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
The ACE gene is localized on chromosome 17q23 and is characterized by a major insertion/deletion polymorphism consisting of the presence or absence of a 287-base pair Alu repeat sequence within intron 16 (15). Angiotensin converting enzyme is an ectoenzyme found on the external surface of the endothelial and epithelial cell membranes. It enhances the synthesis of angiotensin-II, that promotes proliferation, migration, and hypertrophy of vascular smooth muscle cells. Angiotensin II also induces the production of proinflammatory cytokines and matrix metalloproteinases (16, 17). Moreover, the increased free radical generation by angiotensin-II contributes to endothelial dysfunction (18, 19).
###end p 22
###begin p 23
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 488 491 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
In humans, the ACE activity is partly under genetic control. It is suggested that about half of the interindividual difference in ACE levels may be accounted for its polymorphism (19, 20). It is reported that mean ACE levels were lowest for II homozygotes, highest for DD homozygotes, and intermediate for ID heterozygotes (18, 21). Danser et al. explained the higher ACE levels observed in subjects with D allele than those with the II genotype by the sequence harbored in the insert of ACE gene. This sequence was said to be very similar to a silencer element (22). But it is not clear whether increased levels of ACE actually affects the levels of angiotenisn II because the renin-angiotensin system is regulated by feedback mechanism (22).
###end p 23
###begin p 24
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Angiotensin converting enzyme is mainly produced by vascular endothelial cells (23). In Kawasaki disease, the associated endothelial cell damage subsequently lowers the ACE level. It is reported in some literature (24, 25) that serum ACE levels are significantly attenuated during the acute phase, and recovered during the convalescent phase of Kawasaki disease.
###end p 24
###begin p 25
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
Slowik et al. (26) reported that the II genotype of ACE gene contributes to vascular dilatation at the site of aneurysm by 1) increased bradykinin activity, 2) another polymorphism responsible for vascular dilatation that is in linkage disequilibrium with ACE I/D polymorphism, 3) degeneration of endothelial cells, or 4) lack of vascular remodeling.
###end p 25
###begin p 26
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
There is pathological difference between adult coronary artery disease (CAD) and that caused by Kawasaki disease. CAD caused by Kawasaki disease is characterized by vascular intimal thickening, whereas the adult CAD is characterized by atherosclerotic lesions initiated by atheroma and plaque formation. Thus, the pathophysiologic mechanism of myocardial ischemic development is also different; in adult CAD, plaque rupture and thrombus formation plays the important role, whereas in Kawasaki disease, coronary arterial narrowing by intimal hyperplasia is responsible (24).
###end p 26
###begin p 27
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 437 440 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 883 886 883 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
In this study, the ID genotype was more prevalent (59.3 vs. 30.2%, p<0.01), and the DD genotype (12.9 vs. 41.9%, p<0.01) was less prevalent in Kawasaki group than in control group. And I allele was more prevalent in Kawasaki group than in control group. However, both genotype (DD, ID, II) and allelic frequencies were not statistically different between Kawasaki disease patients with coronary dilatations and those without. Therefore, ACE gene I/D polymorphism was thought to be associated with the prevalence of Kawasaki disease but not with the development of coronary lesions. These results are similar to the report by Wu et al. (13) that the DD genotype was present in lower frequency among Kawasaki patients and ACE polymorphism was not associated with coronary aneurysmal formation. These results are different from the study by Takeuchi et al. (27) that the II genotype of ACE gene is more prevalent in Kawasaki disease and those with coronary aneurysm. These inconsistent results may be accounted for different ethnic traits of the individual population.
###end p 27
###begin p 28
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
In conclusion, the ID genotype is present in a significantly higher frequency and DD in lower frequency among Kawasaki disease patients than in control subjects. In addition, there are no significant association between ACE I/D polymorphism and the coronary artery aneurysm formation in Kawasaki disease patients. Because the study groups are relatively small size in number, it is difficult to generalize these results. In this study, the coronary arterial dilatation was observed in 17 out of 55 Kawasaki patients. This is higher than that in previously reported literature. It can be accounted for either 1) longer duration from the onset of illness to the infusion of immunoglobulin, 2) other factors that may affect the development of coronary arterial lesions in Kawasaki disease, such as different ethinicity or 3) selection bias caused by limited number of enrolled institution and small number of patients. IVIG is recommended to be given within the first 10 days of illness and, if possible, within 7 days of illness. Since the duration of febrile days before the diagnosis and the IVIG infusion were 4.6+/-1.6 days (range, 2-8 days) in our study groups, the first explanation seems less likely.
###end p 28
###begin p 29
Further study is required to clarity the association.
###end p 29
###begin article-title 30
Kawasaki disease
###end article-title 30
###begin article-title 31
14th nationwide survey on Kawasaki disease
###end article-title 31
###begin article-title 32
Does Kawasaki disease have a retroviral aetiology?
###end article-title 32
###begin article-title 33
###xml 28 33 <span type="species:ncbi:9606">human</span>
Association between a novel human Coronavirus and Kawasaki disease
###end article-title 33
###begin article-title 34
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease
###end article-title 34
###begin article-title 35
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 41 47 <span type="species:ncbi:9606">infant</span>
Isolation of human herpesvirus-6 from an infant with Kawasaki disease
###end article-title 35
###begin article-title 36
###xml 9 36 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease
###end article-title 36
###begin article-title 37
Kawasaki disease associated with chickenpox: report of two sibling cases
###end article-title 37
###begin article-title 38
The role of EBV in the development of Kawasaki disease
###end article-title 38
###begin article-title 39
###xml 25 33 <span type="species:ncbi:9606">children</span>
Adenoviral infections in children: the impact of rapid diagnosis
###end article-title 39
###begin article-title 40
Immunologic aspect in Kawasaki disease
###end article-title 40
###begin article-title 41
Kawasaki syndrome
###end article-title 41
###begin article-title 42
Polymorphism of angiotenisn-1 converting enzyme gene and Kawasaki disease
###end article-title 42
###begin article-title 43
Structure of angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene
###end article-title 43
###begin article-title 44
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms
###end article-title 44
###begin article-title 45
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Angiotensin converting enzyme and angiotensin II type I receptor polymorphisms in patients with coronary aneurysms
###end article-title 45
###begin article-title 46
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity
###end article-title 46
###begin article-title 47
ACE insert/delete polymorphism and atherosclerosis
###end article-title 47
###begin article-title 48
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
###end article-title 48
###begin article-title 49
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I converting enzyme (ACE) gene controls plasma ACE levels
###end article-title 49
###begin article-title 50
The angiotensin-converting enzyme (ACE) gene insertion/deletion dimorphism tracks with higher serum ACE activities in both younger and older subjects
###end article-title 50
###begin article-title 51
Renin-angiotensin system gene polymorphism: potential mechanisms for their association with cardiovascular diseases
###end article-title 51
###begin article-title 52
Angiotensin converting enzyme: vascular endothelial localization
###end article-title 52
###begin article-title 53
Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease
###end article-title 53
###begin article-title 54
###xml 187 195 <span type="species:ncbi:9606">patients</span>
Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease
###end article-title 54
###begin article-title 55
II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm
###end article-title 55
###begin article-title 56
###xml 82 90 <span type="species:ncbi:9606">patients</span>
High incidence of angiotensin 1 converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm
###end article-title 56
###begin p 57
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Demographic characteristics of Kawasaki disease patients and control group
###end p 57
###begin p 58
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p>0.05. Co A., coronary artery.
###end p 58
###begin p 59
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Prevalence of angiotensin converting enzyme genotype in Kawasaki disease patients and control group
###end p 59
###begin p 60
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 25 31 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 31 32 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.01; odds ratio=0.2; daggerp<0.01; odds ratio=3.3. ACE, angiotensin converting enzyme.
###end p 60
###begin p 61
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Deletion/insertion allelic prevalence of angiotensin converting enzyme gene in Kawasaki disease patients and control group
###end p 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05. odds ratio=1.78.
###end p 62
###begin p 63
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Angiotensin converting enzyme genotype of Kawasaki patients with and without coronary dilatation
###end p 63
###begin p 64
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p>0.05. Co A., coronary artery; ACE, angiotensin converting enzyme.
###end p 64
###begin p 65
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Deletion/insertion allelic prevalence of angiotensin converting enzyme gene of Kawasaki patients with and without coronary dilatation
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p>0.05. Co A., coronary artery.
###end p 66

